Which Lymph Node Dissection Template is Optimal for Radical Cystectomy? A Systematic Review and Bayesian Network Meta-analysis

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Dec 12

PMID 36505883

Authors

Wenqiang Qi

Minglei Zhong

Ning Jiang

Yongheng Zhou

Guangda Lv

Rongyang Li

BenKang Shi

ShouZhen Chen

Affiliations

Soon will be listed here.

Abstract

Objective: This study aims to determine the optimal pelvic lymph node dissection (PLND) template for radical cystectomy (RC).

Methods: A systematic search was conducted using the PubMed, Embase and Cochrane Library database in December 2021. Articles comparing recurrence-free survival (RFS), disease-specific survival (DSS), overall survival (OS), and postoperative complications among patients undergoing limited PLND (lPLND), standard PLND (sPLND), extended PLND (ePLND), or super-extended PLND (sePLND) were included. A Bayesian approach was used for network meta-analysis.

Results: We included 18 studies in this systematic review, and 17 studies met our criteria for network meta-analysis. We performed meta-analyses and network meta-analyses to investigate the associations between four PLND templates and the RFS, DSS, OS, or postoperative complications. We found that the ePLND group and the sePLND group were associated with better RFS than the sPLND group (Hazard Ratio [HR]: 0.65, 95% Credible Interval [CrI]: 0.56 to 0.78) (HR: 0.67, 95% CrI: 0.56 to 0.83) and the lPLND group (HR: 0.67, 95% CrI: 0.50 to 0.91) (HR: 0.70, 95% CrI: 0.49 to 0.99). For RFS, Analysis of the treatment ranking revealed that ePLND had the highest probabilities to be the best template. There was no significant difference between the four templates in DSS, however, analysis of the treatment ranking indicated that sePLND had the highest probabilities to be the best template. And We found that the sePLND group and the ePLND group were associated with better OS than lPLND (HR: 0.58, 95% CrI: 0.36 to 0.95) (HR: 0.63, 95% CrI: 0.41 to 0.94). For OS, analysis of the treatment ranking revealed that sePLND had the highest probabilities to be the best template. The results of meta-analyses and network meta-analyses showed that postoperative complications rates did not differ significantly between any two templates.

Conclusion: Patients undergoing sePLND and ePLND had better RFS but not better DSS or OS than those undergoing lPLND or sPLND templates, however, RFS did not differ between patients undergoing sePLND or ePLND. Considering that sePLND involves longer operation time, higher risk, and greater degree of difficulty than ePLND, and performing sePLND may not result in better prognosis, so it seems that there is no need for seLPND. We think that ePLND might be the optimal PLND template for RC.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42022318475.

References

Zehnder P, Studer U, Skinner E, Dorin R, Cai J, Roth B . Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011; 186(4):1261-8. DOI: 10.1016/j.juro.2011.06.004. View

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

Herr H, Lee C, Chang S, Lerner S . Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol. 2004; 171(5):1823-8. DOI: 10.1097/01.ju.0000120289.78049.0e. View

Bi L, Huang H, Fan X, Li K, Xu K, Jiang C . Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies. BJU Int. 2013; 113(5b):E39-48. DOI: 10.1111/bju.12371. View

Autenrieth M, Nawroth R, Semmlack S, Gschwend J, Retz M . [Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes]. Urologe A. 2008; 47(9):1157-61. DOI: 10.1007/s00120-008-1829-8. View

Bruins H, Huang G, Cai J, Skinner D, Stein J, Penson D . Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol. 2009; 182(5):2182-7. DOI: 10.1016/j.juro.2009.07.017. View

Mandel P, Tilki D, Eslick G . Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis. Urol Oncol. 2014; 32(8):1184-90. DOI: 10.1016/j.urolonc.2014.01.017. View

Zhu X, Zhong Z, Zhang X, Zhang L, Zhao X, Lv C . Comorbidity relationship to outcome of radical cystectomy in Chinese: a single institution study with the ACE-27 comorbidity index. Asian Pac J Cancer Prev. 2012; 13(3):827-31. DOI: 10.7314/apjcp.2012.13.3.827. View

DAndrea D, Abufaraj M, Soria F, Gust K, Haitel A, Krakiewicz P . Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization. World J Urol. 2019; 38(1):121-128. PMC: 6954123. DOI: 10.1007/s00345-019-02769-9. View

10.

Nakagawa T . Lymph node dissection for bladder cancer: Current standards and the latest evidence. Int J Urol. 2020; 28(1):7-15. DOI: 10.1111/iju.14398. View

11.

Abdi H, Pourmalek F, Gleave M, So A, Black P . Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy. World J Urol. 2015; 34(1):41-8. DOI: 10.1007/s00345-015-1734-x. View

12.

Jensen J, Ulhoi B, Jensen K . Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol. 2011; 19(1):39-47. DOI: 10.1111/j.1442-2042.2011.02887.x. View

13.

Honma I, Masumori N, Sato E, Maeda T, Hirobe M, Kitamura H . Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection. Urology. 2006; 68(3):543-8. DOI: 10.1016/j.urology.2006.03.049. View

14.

Hugen C, Polcari A, Fitzgerald M, Dauw C, Flanigan R, Quek M . Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer. J Surg Oncol. 2010; 102(4):334-7. DOI: 10.1002/jso.21642. View

15.

Dhar N, Klein E, Reuther A, Thalmann G, Madersbacher S, Studer U . Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008; 179(3):873-8. DOI: 10.1016/j.juro.2007.10.076. View

16.

Brunocilla E, Pernetti R, Schiavina R, Borghesi M, Vagnoni V, Rocca G . The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer. Int Urol Nephrol. 2013; 45(3):711-9. DOI: 10.1007/s11255-013-0461-8. View

17.

Stein J, Cai J, Groshen S, Skinner D . Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003; 170(1):35-41. DOI: 10.1097/01.ju.0000072422.69286.0e. View

18.

Dharaskar A, Kumar V, Kapoor R, Jain M, Mandhani A . Does extended lymph node dissection affect the lymph node density and survival after radical cystectomy?. Indian J Cancer. 2011; 48(2):230-3. DOI: 10.4103/0019-509X.82896. View

19.

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

20.

Stein J, Lieskovsky G, Cote R, Groshen S, Feng A, Boyd S . Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19(3):666-75. DOI: 10.1200/JCO.2001.19.3.666. View